October 31, 2025

Aurore Life Sciences, established in 2017, is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, offering high-quality, affordable bulk drug solutions to over 55 countries worldwide. With a pure-play focus on APIs and intermediates, Aurore is a fully backward-integrated pharmaceutical company dedicated to delivering to all regulated markets globally.

At the heart of our business model is complete backward integration, ensuring control over every stage of production—from raw materials to the final API. This streamlined process guarantees not only an uninterrupted supply chain but also enhances product consistency, quality, and cost-efficiency. By reducing our reliance on external suppliers, Aurore Life Sciences offers customers a reliable and uninterrupted supply of essential APIs and intermediates, positioning us as the preferred supplier of choice in the industry.

Our diverse product portfolio comprises over 60 APIs, more than 122 Drug Master Files (DMFs), and over 100 intermediates. Supported by state-of-the-art manufacturing facilities, we meet the evolving needs of pharmaceutical companies worldwide.

Aurore Life Sciences strictly adhering to cGMP guidelines. Our manufacturing units have undergone numerous inspections by regulatory bodies such as USFDA, HPRA, AGES, EMEA, EDQM, COFEPRIS, PMDA, TGA, WHO-Geneva, KFDA, ANVISA, and certifications like ISO 9001:2008 and OHSAS 18001:2007. This commitment to quality and compliance underscores our dedication to delivering safe, effective, and reliable pharmaceutical ingredients.

With cutting-edge facilities, a strong emphasis on innovation, and sustainability embedded in our core values, Aurore Life Sciences continues to earn its reputation for excellence in the industry. We remain committed to making essential medicines accessible globally while partnering with leading pharmaceutical companies to meet the healthcare needs of people worldwide.

DATE AND TIME:

Date: 27 September – 30 September , 

Time: 9.30 AM – 5.30 PM

Venue: Aurore Life Science Pvt Ltd., – R&D Centre, Plot No: 90/K, IDA Phase I, Jeedimetla, Chinthal, Jeedimetla, Hyderabad, Telangana 500054

JOB DETAILS:

  • Location: Hyderabad
  • Department: Research & Development (R&D) API Division
  • Reporting to: Manager
  • Experience: 0-2 years
  • Education: M.Sc. in Organic Chemistry
  • Salary: 1.75-3.25 Lacs P.A.

Responsibilities:

Route Design and Synthesis:

  • Conduct literature and patent searches (e.g., using SciFinder, Reaxys).
  • Propose and develop synthetic routes for new and existing APIs.
  • Synthesize intermediates and APIs on lab scale.

Process Development:

  • Optimize reactions for yield, purity, and scalability.
  • Participate in scale-up activities from lab to kilo lab and pilot plant.
  • Develop cost-effective and environmentally friendly processes.

Analytical Support:

  • Work with Analytical R&D to characterize synthesized compounds (e.g., NMR, HPLC, GC, IR, MS).
  • Prepare samples for stability and impurity profiling.

Documentation:

  • Maintain accurate and detailed lab notebooks.
  • Draft technical documents: process development reports, technology transfer dossiers, etc.
  • Ensure compliance with regulatory guidelines (ICH, GMP, etc.).

Collaboration:

  • Interact with cross-functional teams Analytical, Regulatory Affairs, QA/QC, and Manufacturing.
  • Support technology transfer to manufacturing locations.

Key Skills and Competencies:

  • Strong theoretical and practical knowledge in organic synthesis and reaction mechanisms.
  • Familiarity with GMP practices, regulatory norms (ICH Q11, Q7).
  • Experience in reaction optimizationpurification techniques, and problem solving.
  • Proficiency in tools like SciFinder, Reaxys, and analytical instruments (HPLC, NMR, GC).
  • Good communication skills and teamwork orientation.
  • Ability to handle multiple projects and meet tight deadlines.

For More JOB Updates Join Our Whatsapp Group Click Here

Leave a Reply

Your email address will not be published. Required fields are marked *